دورية أكاديمية

Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation.

التفاصيل البيبلوغرافية
العنوان: Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation.
المؤلفون: Manoli I; Metabolic Medicine Branch, National Human Genome Research Institute., Sysol JR; Metabolic Medicine Branch, National Human Genome Research Institute., Head PE; Metabolic Medicine Branch, National Human Genome Research Institute., Epping MW; Metabolic Medicine Branch, National Human Genome Research Institute., Gavrilova O; Mouse Metabolism Core, National Institute of Diabetes and Digestive and Kidney Diseases., Crocker MK; Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development; and., Sloan JL; Metabolic Medicine Branch, National Human Genome Research Institute., Koutsoukos SA; Metabolic Medicine Branch, National Human Genome Research Institute., Wang C; Metabolic Medicine Branch, National Human Genome Research Institute., Ktena YP; Metabolic Medicine Branch, National Human Genome Research Institute., Mendelson S; Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development; and., Pass AR; Metabolic Medicine Branch, National Human Genome Research Institute., Zerfas PM; Office of Research Services, Division of Veterinary Resources, NIH, Bethesda, Maryland, USA., Hoffmann V; Office of Research Services, Division of Veterinary Resources, NIH, Bethesda, Maryland, USA., Vernon HJ; Department of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Fletcher LA; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases., Reynolds JC; Radiology and Imaging Sciences Department, Clinical Center., Tsokos MG; Ultrastructural Pathology Section, Center for Cancer Research; and., Stratakis CA; Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA., Voss SD; Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Chen KY; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases., Brown RJ; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases., Hamosh A; Department of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Berry GT; Division of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Chen XS; Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, Maryland, USA., Yanovski JA; Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development; and., Venditti CP; Metabolic Medicine Branch, National Human Genome Research Institute.
المصدر: JCI insight [JCI Insight] 2024 Feb 22; Vol. 9 (4). Date of Electronic Publication: 2024 Feb 22.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Ann Arbor, Michigan : American Society for Clinical Investigation, [2016]-
مواضيع طبية MeSH: Amino Acid Metabolism, Inborn Errors*/complications , Amino Acid Metabolism, Inborn Errors*/genetics , Amino Acid Metabolism, Inborn Errors*/metabolism , Fibroblast Growth Factors* , Lipodystrophy*, Animals ; Humans ; Mice ; Mice, Transgenic
مستخلص: A distinct adipose tissue distribution pattern was observed in patients with methylmalonyl-CoA mutase deficiency, an inborn error of branched-chain amino acid (BCAA) metabolism, characterized by centripetal obesity with proximal upper and lower extremity fat deposition and paucity of visceral fat, that resembles familial multiple lipomatosis syndrome. To explore brown and white fat physiology in methylmalonic acidemia (MMA), body composition, adipokines, and inflammatory markers were assessed in 46 patients with MMA and 99 matched controls. Fibroblast growth factor 21 levels were associated with acyl-CoA accretion, aberrant methylmalonylation in adipose tissue, and an attenuated inflammatory cytokine profile. In parallel, brown and white fat were examined in a liver-specific transgenic MMA mouse model (Mmut-/- TgINS-Alb-Mmut). The MMA mice exhibited abnormal nonshivering thermogenesis with whitened brown fat and had an ineffective transcriptional response to cold stress. Treatment of the MMA mice with bezafibrates led to clinical improvement with beiging of subcutaneous fat depots, which resembled the distribution seen in the patients. These studies defined what we believe to be a novel lipodystrophy phenotype in patients with defects in the terminal steps of BCAA oxidation and demonstrated that beiging of subcutaneous adipose tissue in MMA could readily be induced with small molecules.
References: Metabolism. 1974 Oct;23(10):937-45. (PMID: 4412181)
Mol Metab. 2016 Aug 06;5(10):926-936. (PMID: 27689005)
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13552-7. (PMID: 23898205)
Nat Rev Endocrinol. 2014 Dec;10(12):723-36. (PMID: 25287287)
Intern Med. 2006;45(17):1001-5. (PMID: 17016000)
Cell Metab. 2012 May 2;15(5):606-14. (PMID: 22560213)
Nature. 2018 Aug;560(7716):102-106. (PMID: 30022159)
Mol Metab. 2017 May 04;6(9):1052-1065. (PMID: 28951828)
Sci Rep. 2021 Jul 30;11(1):15510. (PMID: 34330933)
Pediatr Res. 2007 Aug;62(2):225-30. (PMID: 17597648)
Biochimie. 2017 Mar;134:127-137. (PMID: 28109720)
PLoS One. 2012;7(9):e44335. (PMID: 22962610)
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14163-8. (PMID: 17715058)
J Inherit Metab Dis. 2015 Nov;38(6):1059-74. (PMID: 25875216)
Elife. 2017 Apr 19;6:. (PMID: 28414270)
Cell Metab. 2016 Mar 8;23(3):427-40. (PMID: 26959184)
Br J Dermatol. 2000 Nov;143(5):1113-4. (PMID: 11069542)
Hum Mol Genet. 2023 Aug 26;32(17):2717-2734. (PMID: 37369025)
J Inherit Metab Dis. 2015 Mar;38(2):373-4. (PMID: 25331908)
J Inherit Metab Dis. 2018 Nov;41(6):1179-1187. (PMID: 30159853)
J Clin Invest. 2001 Nov;108(9):1379-85. (PMID: 11696583)
Sci Rep. 2016 Jul 04;6:28775. (PMID: 27373929)
Arch Endocrinol Metab. 2017 Jan-Feb;61(1):7-13. (PMID: 27598976)
EMBO Mol Med. 2020 Mar 6;12(3):e11589. (PMID: 32107855)
FASEB J. 2009 Apr;23(4):1252-61. (PMID: 19088183)
Hum Mutat. 2006 Jan;27(1):31-43. (PMID: 16281286)
J Clin Invest. 2022 Apr 15;132(8):. (PMID: 35230976)
Dentomaxillofac Radiol. 2007 Jan;36(1):51-4. (PMID: 17329589)
Sci Transl Med. 2022 May 25;14(646):eabn4772. (PMID: 35613279)
Int J Obes (Lond). 2020 Aug;44(8):1793-1799. (PMID: 32461554)
Hum Mutat. 2016 Aug;37(8):745-54. (PMID: 27167370)
N Engl J Med. 2009 Feb 19;360(8):838-40. (PMID: 19228633)
Hum Mol Genet. 2012 Dec 1;21(23):5091-105. (PMID: 22922230)
Int J Obes Relat Metab Disord. 2002 Feb;26(2):253-61. (PMID: 11850759)
Nutr Metab Cardiovasc Dis. 2015 Apr;25(4):347-53. (PMID: 25770761)
Ann Neurol. 1991 May;29(5):566-9. (PMID: 1650162)
PLoS One. 2019 Mar 26;14(3):e0214122. (PMID: 30913280)
Annu Rev Nutr. 1984;4:409-54. (PMID: 6380539)
Nature. 2013 Mar 21;495(7441):379-83. (PMID: 23485971)
Cell Metab. 2011 Jul 6;14(1):80-90. (PMID: 21723506)
Arch Biochem Biophys. 2004 Nov 15;431(2):271-8. (PMID: 15488476)
J Proteome Res. 2012 Mar 2;11(3):1633-43. (PMID: 22309199)
Physiol Rev. 2004 Jan;84(1):277-359. (PMID: 14715917)
J Clin Invest. 2013 Aug;123(8):3395-403. (PMID: 23867626)
Mol Metab. 2020 Jun;36:100964. (PMID: 32248079)
JIMD Rep. 2016;28:29-39. (PMID: 26510853)
Sci Rep. 2017 Oct 27;7(1):14248. (PMID: 29079756)
Cell Metab. 2017 Nov 7;26(5):764-777.e5. (PMID: 28988822)
J Clin Invest. 1977 Dec;60(6):1221-9. (PMID: 199616)
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23505-23511. (PMID: 31685628)
J Inherit Metab Dis. 2019 Sep;42(5):730-744. (PMID: 31119747)
Cell Metab. 2009 Apr;9(4):311-26. (PMID: 19356713)
Cell Metab. 2021 May 4;33(5):905-922.e6. (PMID: 33887198)
Neurology. 1994 May;44(5):862-6. (PMID: 8190288)
Hum Mol Genet. 2012 Mar 1;21(5):1124-37. (PMID: 22095692)
Cell Metab. 2011 Dec 7;14(6):715-6; author reply 717. (PMID: 22152297)
Am J Clin Nutr. 2011 Jan;93(1):47-56. (PMID: 21048060)
Nat Rev Mol Cell Biol. 2016 Nov;17(11):691-702. (PMID: 27552974)
Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165622. (PMID: 31770620)
Genet Med. 2021 Aug;23(8):1522-1533. (PMID: 33820958)
Br J Pharmacol. 2014 Apr;171(8):1818-36. (PMID: 24102298)
Nat Rev Immunol. 2011 Feb;11(2):85-97. (PMID: 21252989)
Nat Med. 2012 Mar 06;18(3):363-74. (PMID: 22395709)
Am J Physiol Endocrinol Metab. 2013 Jun 1;304(11):E1175-87. (PMID: 23512805)
Nat Med. 2011 Apr;17(4):448-53. (PMID: 21423183)
Diabetes. 2007 Jun;56(6):1647-54. (PMID: 17360978)
Sci Rep. 2019 Jan 31;9(1):1106. (PMID: 30705343)
J Inherit Metab Dis. 2020 Sep;43(5):981-993. (PMID: 32118306)
J Clin Invest. 2014 Feb;124(2):515-27. (PMID: 24401271)
N Engl J Med. 1983 Apr 14;308(15):857-61. (PMID: 6132336)
Eur J Paediatr Neurol. 2000;4(2):63-7. (PMID: 10817486)
Genet Med. 2016 Apr;18(4):386-95. (PMID: 26270765)
Cell Metab. 2007 Jun;5(6):426-37. (PMID: 17550778)
Mol Metab. 2021 Oct;52:101261. (PMID: 34044180)
Annu Rev Physiol. 2016;78:223-41. (PMID: 26654352)
Mol Metab. 2016 Apr 22;5(7):538-551. (PMID: 27408778)
Hum Mol Genet. 2012 Feb 1;21(3):526-35. (PMID: 22012983)
J Inherit Metab Dis. 2015 Mar;38(2):371-2. (PMID: 25310995)
Clin Nutr. 2005 Jun;24(3):367-74. (PMID: 15896422)
Nat Commun. 2020 Feb 20;11(1):970. (PMID: 32080200)
Nat Chem Biol. 2018 Nov;14(11):1021-1031. (PMID: 30327559)
JCI Insight. 2018 Dec 6;3(23):. (PMID: 30518688)
Lancet. 2019 Dec 22;392(10165):2705-2717. (PMID: 30554783)
Nat Med. 2001 Aug;7(8):941-6. (PMID: 11479627)
J Biol Chem. 2010 Apr 9;285(15):11348-56. (PMID: 20093359)
J Sports Sci Med. 2015 Aug 11;14(3):620-6. (PMID: 26336349)
Annu Rev Pathol. 2010;5:297-348. (PMID: 20078222)
J Clin Lipidol. 2018 Nov - Dec;12(6):1420-1435. (PMID: 30158064)
J Clin Invest. 2005 Jun;115(6):1627-35. (PMID: 15902306)
Crit Rev Biochem Mol Biol. 2022 Apr;57(2):133-155. (PMID: 34608838)
Mol Ther Nucleic Acids. 2014 Oct 07;3:e201. (PMID: 25291143)
Mol Genet Metab. 2022 Jan;135(1):63-71. (PMID: 34991945)
Muscle Nerve. 2006 Jan;33(1):142-6. (PMID: 16007676)
Nat Rev Mol Cell Biol. 2013 Mar;14(3):133-9. (PMID: 23361334)
Diabetes. 2000 Nov;49(11):1910-6. (PMID: 11078459)
Cell Death Differ. 2016 Feb;23(2):279-90. (PMID: 26184910)
J Inherit Metab Dis. 2021 May;44(3):566-592. (PMID: 33595124)
PLoS One. 2015 Aug 25;10(8):e0136571. (PMID: 26305325)
J Physiol. 2018 Feb 15;596(4):623-645. (PMID: 29266268)
Gastroenterology. 2014 Feb;146(2):539-49.e7. (PMID: 24184811)
J Clin Neuromuscul Dis. 2003 Sep;5(1):1-7. (PMID: 19078716)
Cell Metab. 2016 May 10;23(5):770-84. (PMID: 27166942)
Obes Surg. 2008 Oct;18(10):1354-6. (PMID: 18528737)
Hum Mol Genet. 2019 Jan 1;28(1):143-154. (PMID: 30256948)
معلومات مُعتمدة: ZIA DK071014 United States ImNIH Intramural NIH HHS; ZIA HD000641 United States ImNIH Intramural NIH HHS; ZIA HG200318 United States ImNIH Intramural NIH HHS
فهرسة مساهمة: Keywords: Amino acid metabolism; Genetics; Mouse models; Obesity; Therapeutics
المشرفين على المادة: 0 (fibroblast growth factor 21)
62031-54-3 (Fibroblast Growth Factors)
0 (FGF21 protein, human)
SCR Disease Name: Methylmalonic acidemia
تواريخ الأحداث: Date Created: 20240125 Date Completed: 20240224 Latest Revision: 20240330
رمز التحديث: 20240330
مُعرف محوري في PubMed: PMC10967474
DOI: 10.1172/jci.insight.174097
PMID: 38271099
قاعدة البيانات: MEDLINE